🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2b clinical study, multicenter, randomized, open-label, ass...
Status
Completed
Location
University of Alabama Hospital - Infectious Diseases
Start Date
2021-04-22
Trial ID
NCT04775953
Treatments Being Tested
The purpose of this study is to understand the effects of long-term treatme...
Status
Active Not Recruiting
Location
Wayne State University School of Medicine
Start Date
2024-04-02
Trial ID
NCT06180278
Treatments Being Tested
The purpose of this 8-week open-label study is to assess the tolerability, ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2017-04-13
Trial ID
NCT03724552
This phase II trial compares the effect of erdafitinib alone to using the c...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-12
Trial ID
NCT05564416
This phase II trial tests the safety and effectiveness of preoperative immu...
Status
Not Yet Recruiting
Location
Northwestern University
Start Date
2027-12-10
Trial ID
NCT07639528
The objective of this study is to evaluate the safety and efficacy of eculi...
Status
Terminated
Location
Clinical Trial Site
Start Date
2020-01-14
Trial ID
NCT04155424
Treatments Being Tested
Prospective, multicenter, randomized, open-label study of standard of care ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-01-09
Trial ID
NCT03901807
Treatments Being Tested
The aim of the investigators' study was to evaluate oral and non carbapenem...
Status
Unknown
Location
Faculty of Medicine Ramathibodi Hospital
Start Date
2012-11
Trial ID
NCT02537847
Treatments Being Tested
Researchers at Arkansas Children's Hospital Research Institute are conducti...
Status
Terminated
Location
Arkansas Children's Hospital Research Institute
Start Date
2012-05
Trial ID
NCT01602016
Treatments Being Tested
This will be an 8-week open-label trial, using daily doses of paliperidone ...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2007-11
Trial ID
NCT00592358
Treatments Being Tested